These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Non-contrast brain ct based systemic thrombolysis of two wake up ischemic stroke patients in rural settings]. Pozsegovits K; Rencz L; Csúsz L; Szabó G Ideggyogy Sz; 2017 May; 70(5-6):209-212. PubMed ID: 29870636 [TBL] [Abstract][Full Text] [Related]
23. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study. Thomalla G; Kruetzelmann A; Siemonsen S; Gerloff C; Rosenkranz M; Röther J; Fiehler J Stroke; 2008 May; 39(5):1616-8. PubMed ID: 18323483 [TBL] [Abstract][Full Text] [Related]
24. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era. Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K; J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823 [TBL] [Abstract][Full Text] [Related]
25. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
26. Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion. Mendonça N; Rodriguez-Luna D; Rubiera M; Boned-Riera S; Ribo M; Pagola J; Piñeiro S; Meler P; Alvarez-Sabin J; Montaner J; Molina CA Stroke; 2012 Feb; 43(2):417-21. PubMed ID: 22135072 [TBL] [Abstract][Full Text] [Related]
27. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis. Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451 [TBL] [Abstract][Full Text] [Related]
28. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke. Hafeez F; Razzaq MA; Levine RL; Ramirez MA J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246 [TBL] [Abstract][Full Text] [Related]
29. A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator. Han W; Sakurada T; Hachisuka R; Kuroya S; Sumi H; Kojima S; Okamoto T; Shibagaki Y; Tsuchihashi Y; Isahaya K; Sasaki N; Hasegawa Y CEN Case Rep; 2018 Nov; 7(2):282-287. PubMed ID: 29949116 [TBL] [Abstract][Full Text] [Related]
30. Outcomes in acute ischemic strokes presenting with disabling neurologic deficits without intracranial vascular occlusion. Shobha N; Bhatia R; Boyko M; Tymchuk S; Kumarpillai G; Smith E; Demchuk AM Int J Stroke; 2011 Oct; 6(5):392-7. PubMed ID: 21645268 [TBL] [Abstract][Full Text] [Related]
31. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Kucinski T; Koch C; Eckert B; Becker V; Krömer H; Heesen C; Grzyska U; Freitag HJ; Röther J; Zeumer H Neuroradiology; 2003 Jan; 45(1):11-8. PubMed ID: 12525948 [TBL] [Abstract][Full Text] [Related]
32. Cerebral venous congestion as indication for thrombolytic treatment. Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553 [TBL] [Abstract][Full Text] [Related]